----------------------------------------------------------------------------------------------------------------------------------- | Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: Evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation |
| Glatt Sophie1, Baeten Dominique L.P.23, Baker Terry S.1, Griffiths Meryn R.1, Ionescu Lucian2, Lawson Alastair D.G.1, Maroof Ash1, Oliver Ruth1, Popa Serghei4, Strimenopoulou Foteini1, Vajjah Pavan1, Watling Mark I.L1, Yeremenko Nataliya G.3, Miossec Pierre J.5, Shaw Stevan1 |
4 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
|
| Annals of the Rheumatic Diseases |
| Nr. / 2018 / ISSN - /ISSNe 0003-4967 |
| Disponibil online 8 May, 2018. Descarcări-0. Vizualizări-826 |
----------------------------------------------------------------------------------------------------------------------------------- | Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: A phase II dose-ranging randomised controlled trial |
| Wallace Daniel J.1, Strand Vibeke2, Merrill Joan T.3, Popa Serghei4, Spindler Alberto J.5, Eimon Aliciaf6, Noi Autori |
1 Cedars-Sinai Medical Center, Los Angeles,
2 Stanford University, Palo Alto,
3 Oklahoma Medical Research Foundation, Oklahoma City,
4 Timofei Moșneaga Republican Clinical Hospital,
5 Private Medical Center of Rheumatology, Tucuman,
6 CEMIC, Buenos Aires |
| Annals of the Rheumatic Diseases |
| Nr. / 2017 / ISSN - /ISSNe 0003-4967 |
| Disponibil online 10 June, 2022. Descarcări-0. Vizualizări-248 |
----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------
1-8 of 8
